Adam Morgan of Velan Capital Investment Management (L) and Radius Health CEO Kelly Martin

Ac­tivist in­vestors at­tempt to change the course at Ra­dius Health, six months af­ter two dis­ap­point­ing read­outs

Fol­low­ing a dis­ap­point­ing da­ta re­veal and sub­se­quent stock drop late last year, Ra­dius Health is now fac­ing an ac­tivist at­tack from two mi­nor­i­ty in­vestors aim­ing to right the ship.

Ve­lan Cap­i­tal In­vest­ment Man­age­ment and Reper­toire Part­ners filed their proxy state­ments Tues­day morn­ing in a bid to nom­i­nate a slate of three new board mem­bers at Ra­dius’ an­nu­al share­hold­er meet­ing next month. The Ve­lan-Reper­toire group, which col­lec­tive­ly owns a 7.7% stake, al­leges Ra­dius’ cur­rent di­rec­tors have un­der­tak­en a bad com­mer­cial strat­e­gy for its one ap­proved prod­uct and are un­fit to serve be­cause they own al­most no shares in the com­pa­ny.

Endpoints News

Unlock this article instantly by becoming a free subscriber.

You’ll get access to free articles each month, plus you can customize what newsletters get delivered to your inbox each week, including breaking news.